Hung‐Jen Wu
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Hung‐Jen Wu has a total of 20 co-authors. Here are the top co-authors by number of shared publications:
- Mark Howarth
Department of Pharmacology, University of Cambridge, Tennis Court Road, Cambridge, CB2 1PD, UK
3 shared publications - Alain Townsend
Chinese Academy of Medical Science Oxford Institute, Nuffield Department of Medicine, University of Oxford
2 shared publications Anne‐Marie C. Andersson
Department of Biochemistry University of Oxford South Parks Road Oxford OX1 3QU UK
2 shared publicationsJordan R. Barrett
Jenner Institute University of Oxford Oxford OX3 7DQ UK
2 shared publications- Pramila Rijal
Chinese Academy of Medical Science Oxford Institute, Nuffield Department of Medicine, University of Oxford
2 shared publications - Rolle Rahikainen
Tampere University Arvo Ylpön katu 34
2 shared publications
Latest Publications
- Top Cited PapersOpen Access
- 12 February 2021
- Published by American Association for the Advancement of Science (AAAS) in Science
- Vol. 371 (6530) , 735-741
Mosaic nanoparticles elicit cross-reactive immune responses to zoonotic coronaviruses in mice
Fighting zoonotic coronaviruses: In the past 20 years, three betacoronaviruses thought to have originated in bats have caused devastating disease in humans. The global pandemic caused by the latest such virus, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), highlights the need to protect against other strains that could present a threat to humans. Cohen et al. constructed nanoparticles displaying the protein domain that binds the host cell receptor (receptor-binding domain or RBD), either a homotypic SARS-CoV-2 particle or mosaic particles displaying RBDs from four or eight different betacoronaviruses. In mice, antibodies to the SARS-CoV-2 RBD were elicited just as well by mosaic particles as by homotypic nanoparticles. The mosaic nanoparticles elicited antibodies that, beyond recognizing the strains displayed, also recognized mismatched strains. Science , this issue p. 735
- 12 February 2021
- Published by American Association for the Advancement of Science (AAAS) in Science
- Vol. 371 (6530) , 735-741
Top Cited PapersOpen AccessMosaic nanoparticles elicit cross-reactive immune responses to zoonotic coronaviruses in mice
Fighting zoonotic coronaviruses: In the past 20 years, three betacoronaviruses thought to have originated in bats have caused devastating disease in humans. The global pandemic caused by the latest such virus, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), highlights the need to protect against other strains that could present a threat to humans. Cohen et al. constructed nanoparticles displaying the protein domain that binds the host cell receptor (receptor-binding domain or RBD), either a homotypic SARS-CoV-2 particle or mosaic particles displaying RBDs from four or eight different betacoronaviruses. In mice, antibodies to the SARS-CoV-2 RBD were elicited just as well by mosaic particles as by homotypic nanoparticles. The mosaic nanoparticles elicited antibodies that, beyond recognizing the strains displayed, also recognized mismatched strains. Science , this issue p. 735
- Open Access
- 4 September 2020
- Published by Wiley in Angewandte Chemie
- Vol. 133 (1) , 325-334
Overcoming Symmetry Mismatch in Vaccine Nanoassembly through Spontaneous Amidation
Matching of symmetry at interfaces is a fundamental obstacle in molecular assembly. Virus‐like particles (VLPs) are important vaccine platforms against pathogenic threats, including Covid‐19. However, symmetry mismatch can prohibit vaccine nanoassembly. We established an approach for coupling VLPs to diverse antigen symmetries. SpyCatcher003 enabled efficient VLP conjugation and extreme thermal resilience. Many people had pre‐existing antibodies to SpyTag:SpyCatcher but less to the 003 variants. We coupled the computer‐designed VLP not only to monomers (SARS‐CoV‐2) but also to cyclic dimers (Newcastle disease, Lyme disease), trimers (influenza hemagglutinins), and tetramers (influenza neuraminidases). Even an antigen with dihedral symmetry could be displayed. For the global challenge of influenza, SpyTag‐mediated display of trimer and tetramer antigens strongly induced neutralizing antibodies. SpyCatcher003 conjugation enables nanodisplay of diverse symmetries towards generation of potent vaccines.
- 4 September 2020
- Published by Wiley in Angewandte Chemie
- Vol. 133 (1) , 325-334
Open AccessOvercoming Symmetry Mismatch in Vaccine Nanoassembly through Spontaneous Amidation
Matching of symmetry at interfaces is a fundamental obstacle in molecular assembly. Virus‐like particles (VLPs) are important vaccine platforms against pathogenic threats, including Covid‐19. However, symmetry mismatch can prohibit vaccine nanoassembly. We established an approach for coupling VLPs to diverse antigen symmetries. SpyCatcher003 enabled efficient VLP conjugation and extreme thermal resilience. Many people had pre‐existing antibodies to SpyTag:SpyCatcher but less to the 003 variants. We coupled the computer‐designed VLP not only to monomers (SARS‐CoV‐2) but also to cyclic dimers (Newcastle disease, Lyme disease), trimers (influenza hemagglutinins), and tetramers (influenza neuraminidases). Even an antigen with dihedral symmetry could be displayed. For the global challenge of influenza, SpyTag‐mediated display of trimer and tetramer antigens strongly induced neutralizing antibodies. SpyCatcher003 conjugation enables nanodisplay of diverse symmetries towards generation of potent vaccines.
- Open Access
- 4 September 2020
- Published by Wiley in Angewandte Chemie International Edition
- Vol. 60 (1) , 321-330
Overcoming Symmetry Mismatch in Vaccine Nanoassembly through Spontaneous Amidation
Matching of symmetry at interfaces is a fundamental obstacle in molecular assembly. Virus‐like particles (VLPs) are important vaccine platforms against pathogenic threats, including Covid‐19. However, symmetry mismatch can prohibit vaccine nanoassembly. We established an approach for coupling VLPs to diverse antigen symmetries. SpyCatcher003 enabled efficient VLP conjugation and extreme thermal resilience. Many people had pre‐existing antibodies to SpyTag:SpyCatcher but less to the 003 variants. We coupled the computer‐designed VLP not only to monomers (SARS‐CoV‐2) but also to cyclic dimers (Newcastle disease, Lyme disease), trimers (influenza hemagglutinins), and tetramers (influenza neuraminidases). Even an antigen with dihedral symmetry could be displayed. For the global challenge of influenza, SpyTag‐mediated display of trimer and tetramer antigens strongly induced neutralizing antibodies. SpyCatcher003 conjugation enables nanodisplay of diverse symmetries towards generation of potent vaccines.
- 4 September 2020
- Published by Wiley in Angewandte Chemie International Edition
- Vol. 60 (1) , 321-330
Open AccessOvercoming Symmetry Mismatch in Vaccine Nanoassembly through Spontaneous Amidation
Matching of symmetry at interfaces is a fundamental obstacle in molecular assembly. Virus‐like particles (VLPs) are important vaccine platforms against pathogenic threats, including Covid‐19. However, symmetry mismatch can prohibit vaccine nanoassembly. We established an approach for coupling VLPs to diverse antigen symmetries. SpyCatcher003 enabled efficient VLP conjugation and extreme thermal resilience. Many people had pre‐existing antibodies to SpyTag:SpyCatcher but less to the 003 variants. We coupled the computer‐designed VLP not only to monomers (SARS‐CoV‐2) but also to cyclic dimers (Newcastle disease, Lyme disease), trimers (influenza hemagglutinins), and tetramers (influenza neuraminidases). Even an antigen with dihedral symmetry could be displayed. For the global challenge of influenza, SpyTag‐mediated display of trimer and tetramer antigens strongly induced neutralizing antibodies. SpyCatcher003 conjugation enables nanodisplay of diverse symmetries towards generation of potent vaccines.